We found that deficiency of Per2 retarded the growth of the GH3 tumor as revealed by reduced tumor volume (Figure 3L-M) and tumor mass (Figure 3N) as well as a lower plasma GH level (Figure 3O). This evidence concerns the gene PER2 and neoplasm.